J&J Discloses Fed. Probes Over Arthritis Drugs, Copayments
By Melissa Daniels ( May 8, 2017, 10:33 PM EDT) -- Johnson & Johnson disclosed to investors on Monday its Janssen Biotech Inc. is under investigation by the U.S. Department of Justice in connection with a False Claims Act case related to two of its arthritis drugs, while also reporting a separate probe by the U.S. attorney's office in Massachusetts over copayment support programs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.